Sterne Kessler Wins $9.5 Million Jury Verdict for Mallinckrodt Pharmaceuticals in Patent Suit
Sterne, Kessler, Goldstein & Fox won a $9.5 million jury verdict on behalf of Mallinckrodt Pharmaceuticals in a patent infringement lawsuit filed in the U.S. District Court for the District of Delaware over Mallinckrodt’s INOmax (nitric oxide for inhalation) drug product and associated nitric oxide delivery device.
Former Deputy Chief Administrative Patent Judge Jackie Wright Bonilla Joins Sterne Kessler
Sterne, Kessler, Goldstein & Fox announced today that Jacqueline (Jackie) D. Wright Bonilla, former Deputy Chief Administrative Patent Judge at the Patent Trial and Appeal Board (PTAB), has joined the firm as a director in the Biotechnology & Chemical and Trial & Appellate Practice Groups.
Sterne Kessler’s Client RoboticVISION Tech, Inc. Obtains Favorable Settlement
Sterne, Kessler, Goldstein & Fox is pleased to announce that its client, RoboticVISION Tech, Inc. (RVT), has settled its lawsuits against its competitors, ABB Inc. and ABB Ltd.
Sterne Kessler Announces Five New Directors in 2025
Sterne, Kessler, Goldstein & Fox proudly announces the election of five new directors, effective January 1, 2025. The newly promoted attorneys are Jennifer Meyer Chagnon, Dohm Chankong, Joseph Kim, Steve Pappas, and Tyler Tassone.
